4/A: Vaxart SVP Corrects Beneficial Ownership Reporting in Amended SEC Filing

Sean Tucker, SVP and Chief Scientific Officer of Vaxart, files an amendment to a previous Form 4 to correct an administrative error regarding the reporting of beneficially owned securities.

Summary

• Sean Tucker, SVP and Chief Scientific Officer of Vaxart, filed an amended Form 4 with the SEC on April 1, 2024.
• This amendment corrects an error in the original Form 4 filed on March 20, 2024.
• The error involved the inclusion of securities indirectly owned through his spouse and joint tenancy with Frances Chang in the amount of securities directly owned by Tucker.
• The corrected filing shows Tucker directly owns 359,597 shares of Vaxart common stock.
• He indirectly owns 51,465 shares through joint tenancy with Frances Chang and Sean Tucker, and 9,060 shares through his spouse.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a minor administrative error. It doesn't indicate any significant positive or negative developments for the company.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions and holdings of company executives.

Key Dates